Nitric oxide-related brain damage in acute ischemic stroke

Stroke

Volumn 31, Issue 4, 2000, Pages 852-857

  Castillo, José ^a   Rama, Ramón ^b   Dávalos, Antoni ^c  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c HOSPITAL JOSEP TRUETA   (Spain)

Author keywords

Excitotoxicity; Nitric oxide; Stroke outcome; Stroke, acute; Tomography, x ray computed

Indexed keywords

NITRIC OXIDE;

AGED; ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; CEREBROSPINAL FLUID; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPROTECTION; NEUROTOXICITY; PRIORITY JOURNAL; RISK FACTOR;

EID: 0034040616     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.31.4.852     Document Type: Article

References (48)

1. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991;43:109-142.
2. Faraci FM, Brian JE Jr. Nitric oxide and the cerebral circulation. Stroke, 1994;25:692-703.
3. Iadecola C, Pelligrino DA, Moscowitz MA, Lassen NA. Nitric oxide synthase inhibition and cerebrovascular regulation. J Cereb Blood Flow Metab. 1994;14:175-192.
4. Dalkara T, Moskowitz MA. The role of nitric oxide in cerebral ischemia. In: Welch KMA, Caplan LR, Reis DJ, Siesjö BK, Weir B, eds. Primer on Cerebrovascular Diseases. San Diego, Calif: Academic Press; 1997: 207-208.
5. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med. 1993;329:2002-2012.
6. Bredt DS, Syndcr SH. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Prof Natl Acad Sci USA. 1990;87:682-685.
7. Dawson VL, Dawson TM. Nitric oxide neurotoxicity. J Chem Neuroanat. 1996;10:179-190.
8. Baumgartner WA, Redmond M, Brock M, Tseng E, Blue ME. Troncoso JC, Johnston MV. Pathophysiology of cerebral injury and future management. J Card Surg. 1997;12(suppl 2):300-310.
9. Forman LJ, Liu P, Nagele RG, Yin K, Wong PY. Augmentation of nitric oxide, superoxide, and peroxynitrite production during cerebral ischemia and reperfusion in the rat. Neurochem Res. 1998;23:141-148.
10. Stagliano NE, Zhao W, Prado R, Dewanjee MK, Ginsberg MD, Dietrich WD. The effect of nitric oxide synthase inhibition on acute platelet accumulation and hemodynamic depression in a rat model of thromboembolic stroke. J Cereb Blood Flow Metab. 1997;17:1182-1190.
11. Dalkara T, Yoshida T, Irikura K, Moskowitz MA. Dual role of nitric oxide in focal cerebral ischemia. Neuropharmacology. 1994;33:1447-1452.
12. Iadecola C. Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci. 1997;20:132-139.
13. Karder A, Frazzini VI, Solomon RA, Trifiletti RR. Nitric oxide production during focal cerebral ischemia in rats. Stroke. 1993;24:1709-1716.
14. Archer S. Measurement of nitric oxide in biological models. FASEB J. 1993;7:349-360.
15. Chabrier PE, Auguet M, Spinnewyn B, Auvin S, Comet S, Demerle-Pallardy C, Guilmard-Favre C, Marin JG, Pignol B, Gillard-Roubert V, Roussillot-Charnet C, Schulz J, Viossat I, Bigg D, Moncada S, BN 80933, a dual inhibitor of neuronal nitric oxide synthase and lipid peroxidation: a promising neuroprotective strategy. Proc Natl Acad Sci USA. 1999;96:10824-10829.
16. Castillo J, Dávalos A, Naveiro J, Noya M, Neuroexcitatory amino acids and their relation to infarct size and neurological deficit in ischemic stroke. Stroke. 1996;27:1060-1065.
17. Castillo J. Dávalos A, Noya M. Progression of ischaemic stroke and excitotoxic amino acids. Lancet. 1997;349:79-83.
18. Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE III, and the TOAST Investigators. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. Stroke. 1993;24:35-41.
19. Castillo J, Dávalos A, Marrugat J, Noya M. Timing for fever-related brain damage in acute ischemic stroke. Stroke. 1998;29:2455-2460.
20. Dávalos A, Cendra E, Teruel J, Martínez M, Genis D. Deteriorating ischemic stroke: risk factors and prognosis. Neurology. 1990;40:1865-1869.
21. Kay R, Wong KS, Perez G, Woo J. Dichotomizing stroke outcomes based on self-reported dependency. Neurology. 1997;49:1694-1696.
22. Sluter G, Steen C, De Keyser J. Use of Barthel index and modified Rankin scale in acute stroke trials. Stroke. 1999;30:1538-1541.
23. Gilliam MB, Sherman MP, Griscavage JM, Ignarro LJ. A spectrophotometric assay for nitrate using NADPH oxidation by aspergillus nitrate reductase. Anal Biochem. 1993;212:359-365.
24. Dávalos A, Castillo J, Pumar JM, Noya M. Body temperature and fibrinogen are related to early neurological deterioration in acute ischemic stroke. Cerebrovasc Dis. 1997;7:64-69.
25. Roben C, Vermont J, Bosson JL. Formulae for threshold computations. Comput Biomed Res. 1991;24:514-529.
26. Foster C, Clark HB, Ross ME, Iadecola C. Inducible nitric oxide synthase expression in human cerebral infarcts. Acta Neuropathol (Bert). 1999;97: 215-220.
27. Zhang F, Casey RM, Ross ME, Iadecola C. Aminoguanidine ameliorates and L-arginine worsens brain damage from intraluminal middle cerebral artery occlusion. Stroke. 1996;27:317-323.
28. Cockroft KM. Meistrell M, Zimmerman GA, Risucci D, Bloom O, Cerami A, Tracey KJ. Cerebroprotective effects of aminoguanidine in a rodent model of stroke. Stroke. 1996;27:1393-1398.
29. Iadecola C, Zhang F, Xu X. Inhibition of inducible nitric oxide synthase ameliorates cerebral ischemic damage. Am J Physiol. 1995;268:R286-R292.
30. Nagayama M, Zhang F, Iadecola C. Delayed treatment with aminoguanidine decreases focal cerebral ischemic damage and enhances neurologic recovery in rats. J Cereb Blood Flow Metab. 1998;18:1107-1113.
31. Huang Z, Huang PL, Panahian N, Dalkara T, Fishman MC, Moskowitz MA. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science. 1994;265:1883-1885.
32. Huang Z, Huang PL, Ma J, Meng W, Ayata C, Fishman MC, Moskowitz MA. Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-L-arginine. J Cereb Blood Flow Metab. 1996;16:981-987.
33. Iadecola C, Zhang F, Casey R, Nagayama M, Ross ME. Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene. J Neurosci. 1997;17:9157-9164.
34. Zhang F, Xu S, Iadecola C. Time dependence of effect of nitric oxide synthase inhibition on cerebral ischemic damage. J Cereb Blood Flow Metab. 1995;15:595-601.
35. Iadecola C, Xu X, Zhang F, el-Fakahany EE, Ross ME. Marked induction of calcium-independent nitric oxide synthase activity after focal cerebral ischemia. J Cereb Blood Flow Metab. 1995;15:52-59.
36. Iadecola C, Zhang F, Xu S, Casey R. Ross ME. Inducible nitric oxide synthase gene expression in brain following cerebral ischemia J Cereb Blood Flow Metab. 1995;15:378-384.
37. Iadecola C, Zhang F, Casey R, Clark HB, Ross ME. Inducible nitric oxide synthase gene expression in vascular cells after transient focal cerebral ischemia. Stroke. 1996;27:1373-1380.
38. Castillo J. Dávalos A, Naveiro J, Armengou A, Noya M. A reduction in L-arginine levels during acute stroke is associated with greater cerebral damage. Cerebrovasc Dis. 1997;7(suppl 4):82. Abstract.
39. Dávalos A, Castillo J, Serena J, Noya M. Duration of glutamate release after acute ischemic stroke. Stroke. 1997;28:708-710.
40. Castillo J, Dávalos A, Lema M, Serena J, Noya M. Glutamate is a marker for cerebral ischemia in cortical but not deep infarcts. Cerebrovasc Dis. 1997;7: 245-250.
41. Dávalos A, Castillo J. Progressing stroke: potential mechanisms of worsening. Cerebrovasc Dis. 1997;8(suppl 5):19-24.
42. Dávalos A, Castillo J. Progressing stroke. In: Fisher M, Bogousslavsky J, eds. Current Review of Cerebrovascular Disease. Boston, Mass: Butterworth-Heinemann; 1999:149-160.
43. Castillo J. Deteriorating stroke: diagnostic criteria predictors, mechanisms and treatment. Cerebrovasc Dis. 1999 (suppl 3):1-8.
44. Ashwal S, Tone B, Tian HR, Cole DJ, Pearce WJ. Core and penumbral nitric oxide synthase activity during cerebral ischemia and reperfusion. Stroke. 1998;29:1037-1046.
45. Beckman JS. Peroxynitrite versus hydroxyl radical: the role of nitric oxide in superoxide-dependent cerebral injury. Ann N Y Acad Sci. 1994;738:69-75.
46. Malinski T, Bailey F, Zhang ZG, Chopp M. Nitric oxide measured by a porphyrinic microsensor in rat brain after transient middle cerebral artery occlusion. J Cereb Blood Flow Metab. 1993;13:355-358.
47. Fukuyama N, Takizawa S, Ishida H, Hoshiai K, Shinohara Y, Nakazawa H. Peroxynitrite formation in focal cerebral ischemia-reperfusion in rats occurs predominantly in the peri-infarct region. J Cereb Blood Flow Metab. 1998; 18:123-129.
48. Kuprinski J, Vodorotz Y, Li C, Slowik A, Beevers D, Flanders KC, Lip G, Kumar P, Szczudlik A. Inducible nitric oxide production and expression of transforming growth factor-beta 1 in serum and CSF after cerebral ischaemic stroke in man. Nitric Oxide. 1998;2:442-453.